What is Banthine used for?

Banthine is indicated for Gastric ulcer, Peptic ulcer, Urinary incontinence.

Banthine is developed by Takeda.

What development phase is Banthine in?

Banthine is FDA-approved (marketed).

What is the generic name of Banthine?

methanthelinium is the generic (nonproprietary) name of Banthine.

Last reviewed 2026-04-20 · How we verify

Banthine (methanthelinium)

Takeda · FDA-approved active Quality 30/100

At a glance

Generic name	methanthelinium
Sponsor	Takeda
Drug class	methantheline
Target	Muscarinic acetylcholine receptor
Therapeutic area	Neuroscience
Phase	FDA-approved
First approval	1951

Approved indications

Gastric ulcer
Peptic ulcer
Urinary incontinence

Common side effects

No common side effects on file.

Key clinical trials

Bioavailability of Vagantin® Coated Tablets Relative to an Oral Methantheline Bromide Solution (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
FDA label	Mechanism, indications, dosing, boxed warnings, drug interactions
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Banthine CI brief — competitive landscape report
Banthine updates RSS · CI watch RSS
Takeda portfolio CI